New drugs from Gilead and Merck set for ‘blockbuster’ status, report shows

03-02-2016

New drugs from Gilead and Merck set for ‘blockbuster’ status, report shows

Pavlo_K / Shutterstock.com

Drugs made by pharmaceutical companies including Abbvie, Gilead, and Merck are set to achieve “blockbuster” status by 2020, according to a report.


Abbvie, Gilead, Intercept, Merck, Thomson Reuters, IP, drugs, blockbuster, therapeutics,

LSIPR